Literature DB >> 35070893

Immune response pathways enriched in breast cancer samples with brain metastasis.

Peng Wang1,2,3,4, Zengfeng Sun1,2,3,4, Zhen Zhang1,2,3,4, Qiang Yin1,2,3,4.   

Abstract

BACKGROUND: Breast cancer (BC) is the most common form of cancer in women. BC brain metastasis (BM) is associated with poor prognosis, especially for Triple negative breast cancer (TNBC). However, the driver genes of this clinical characteristic are poorly understood.
METHODS: This study conducted a transcriptome-wide analysis of gene expression levels in BCBM samples from the Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) datasets. Clinical data and gene expression matrix of TNBC samples were collected. Differential analysis and functional enrichment of metastasis vs. non metastasis data samples were conducted. Genes associated with overall survival and BM event was scanned.
RESULTS: Up-regulation in 120 genes and down-regulation in 56 genes were found in TNBC metastasis data. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) clustering using expression alternated genes showed unique immune-gene enrichment in BM samples. Immune response category GO:000695 was found as the most significant term associated with metastasis event. KEGG pathways including cytokine pathways and Primary immunodeficiency were significantly changed in metastasis samples. ESR1 and FYB2 genes expression changes were found to be linked to survival or BM events.
CONCLUSIONS: Our results suggest that data-mining on the immune microenvironment of BM might be useful in future study. 2021 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Breast cancer (BC); brain metastasis (BM); differential expression analysis; immune profile; transcriptome

Year:  2021        PMID: 35070893      PMCID: PMC8749083          DOI: 10.21037/gs-21-745

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  39 in total

1.  Drug Resistance in HER2-Positive Breast Cancer Brain Metastases: Blame the Barrier or the Brain?

Authors:  Sheheryar Kabraji; Jing Ni; Nancy U Lin; Shaozhen Xie; Eric P Winer; Jean J Zhao
Journal:  Clin Cancer Res       Date:  2018-02-06       Impact factor: 12.531

Review 2.  Ultrasound imaging classifications of thyroid nodules for malignancy risk stratification and clinical management: state of the art.

Authors:  Chiara Floridi; Michaela Cellina; Giorgio Buccimazza; Antonio Arrichiello; Andrea Sacrini; Francesco Arrigoni; Giovanni Pompili; Antonio Barile; Gianpaolo Carrafiello
Journal:  Gland Surg       Date:  2019-09

3.  Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT).

Authors:  A Niwińska; M Murawska; K Pogoda
Journal:  Ann Oncol       Date:  2009-10-19       Impact factor: 32.976

4.  Genes that mediate breast cancer metastasis to the brain.

Authors:  Paula D Bos; Xiang H-F Zhang; Cristina Nadal; Weiping Shu; Roger R Gomis; Don X Nguyen; Andy J Minn; Marc J van de Vijver; William L Gerald; John A Foekens; Joan Massagué
Journal:  Nature       Date:  2009-05-06       Impact factor: 49.962

Review 5.  Chemotaxis, chemokine receptors and human disease.

Authors:  Tian Jin; Xuehua Xu; Dale Hereld
Journal:  Cytokine       Date:  2008-08-21       Impact factor: 3.861

6.  Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer.

Authors:  Jochen Gaedcke; Frank Traub; Simone Milde; Ludwig Wilkens; Alexandru Stan; Helmut Ostertag; Mathias Christgen; Reinhard von Wasielewski; Hans H Kreipe
Journal:  Mod Pathol       Date:  2007-06-01       Impact factor: 7.842

7.  IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis.

Authors:  Kelly Kersten; Chris W Doornebal; Seth B Coffelt; Jorieke Weiden; Kim Vrijland; Cheei-Sing Hau; Niels J M Verstegen; Metamia Ciampricotti; Lukas J A C Hawinkels; Jos Jonkers; Karin E de Visser
Journal:  Nature       Date:  2015-03-30       Impact factor: 49.962

8.  Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients.

Authors:  Ahmet Zehir; Ryma Benayed; Ronak H Shah; Aijazuddin Syed; Sumit Middha; Hyunjae R Kim; Preethi Srinivasan; Jianjiong Gao; Debyani Chakravarty; Sean M Devlin; Matthew D Hellmann; David A Barron; Alison M Schram; Meera Hameed; Snjezana Dogan; Dara S Ross; Jaclyn F Hechtman; Deborah F DeLair; JinJuan Yao; Diana L Mandelker; Donavan T Cheng; Raghu Chandramohan; Abhinita S Mohanty; Ryan N Ptashkin; Gowtham Jayakumaran; Meera Prasad; Mustafa H Syed; Anoop Balakrishnan Rema; Zhen Y Liu; Khedoudja Nafa; Laetitia Borsu; Justyna Sadowska; Jacklyn Casanova; Ruben Bacares; Iwona J Kiecka; Anna Razumova; Julie B Son; Lisa Stewart; Tessara Baldi; Kerry A Mullaney; Hikmat Al-Ahmadie; Efsevia Vakiani; Adam A Abeshouse; Alexander V Penson; Philip Jonsson; Niedzica Camacho; Matthew T Chang; Helen H Won; Benjamin E Gross; Ritika Kundra; Zachary J Heins; Hsiao-Wei Chen; Sarah Phillips; Hongxin Zhang; Jiaojiao Wang; Angelica Ochoa; Jonathan Wills; Michael Eubank; Stacy B Thomas; Stuart M Gardos; Dalicia N Reales; Jesse Galle; Robert Durany; Roy Cambria; Wassim Abida; Andrea Cercek; Darren R Feldman; Mrinal M Gounder; A Ari Hakimi; James J Harding; Gopa Iyer; Yelena Y Janjigian; Emmet J Jordan; Ciara M Kelly; Maeve A Lowery; Luc G T Morris; Antonio M Omuro; Nitya Raj; Pedram Razavi; Alexander N Shoushtari; Neerav Shukla; Tara E Soumerai; Anna M Varghese; Rona Yaeger; Jonathan Coleman; Bernard Bochner; Gregory J Riely; Leonard B Saltz; Howard I Scher; Paul J Sabbatini; Mark E Robson; David S Klimstra; Barry S Taylor; Jose Baselga; Nikolaus Schultz; David M Hyman; Maria E Arcila; David B Solit; Marc Ladanyi; Michael F Berger
Journal:  Nat Med       Date:  2017-05-08       Impact factor: 53.440

9.  Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer.

Authors:  Ji Yun Lee; Kyunghee Park; Sung Hee Lim; Hae Su Kim; Kwai Han Yoo; Ki Sun Jung; Haa-Na Song; Mineui Hong; In-Gu Do; TaeJin Ahn; Se Kyung Lee; Soo Youn Bae; Seok Won Kim; Jeong Eon Lee; Seok Jin Nam; Duk-Hwan Kim; Hae Hyun Jung; Ji-Yeon Kim; Jin Seok Ahn; Young-Hyuck Im; Yeon Hee Park
Journal:  Oncotarget       Date:  2015-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.